XI'AN HAIXIN Pharmaceutical Co., Ltd.
-
Founded in:
1995-09-22 -
Country:
China -
Address:
No. 20, Tuanjie South Road, Xi'an High-tech Development Zone -
Tax NO.:
916101312944622939 -
Registered Funds:
$15 million -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nisoldipine |
Nisoldipine is a dihydropyridine calcium channel antagonist that inhibits the influx of calcium ions across the cell membrane into vascular smooth muscle and myocardial cells. Its effect on vascular smooth muscle is stronger than that on myocardium, leading to dilation of arterioles. Despite its negative inotropic effect in vitro, studies in anesthetized animals have shown that the dose that dilates blood vessels is lower than the dose that affects myocardial contractility.
More
Nisoldipine is a dihydropyridine calcium channel antagonist that inhibits the influx of calcium ions across the cell membrane into vascular smooth muscle and myocardial cells. Its effect on vascular smooth muscle is stronger than that on myocardium, leading to dilation of arterioles. Despite its negative inotropic effect in vitro, studies in anesthetized animals have shown that the dose that dilates blood vessels is lower than the dose that affects myocardial contractility. |
63675-72-9 | 12 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| NATURAL INDIGO |
Not yet clear
More
Not yet clear |
0 | ||
| Aluminium potassium sulfate dodecahydrate |
Not yet clear
More
Not yet clear |
7784-24-9 | 3 | |
| Borneol |
Not yet clear
More
Not yet clear |
507-70-0 | 1 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Disodium pamidronate |
This product is a bisphosphonate drug. In vitro and animal tests have shown that it can strongly inhibit the dissolution of hydroxyapatite and the activity of osteoclasts, and has a very significant inhibitory effect on bone absorption. It has an analgesic effect on pain caused by osteolytic bone metastasis of cancer, and can also be used to treat hypercalcemia caused by cancer.
More
This product is a bisphosphonate drug. In vitro and animal tests have shown that it can strongly inhibit the dissolution of hydroxyapatite and the activity of osteoclasts, and has a very significant inhibitory effect on bone absorption. It has an analgesic effect on pain caused by osteolytic bone metastasis of cancer, and can also be used to treat hypercalcemia caused by cancer. |
109552-15-0 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Disodium pamidronate |
This product is a bisphosphonate drug. In vitro and animal tests have shown that it can strongly inhibit the dissolution of hydroxyapatite and the activity of osteoclasts, and has a very significant inhibitory effect on bone absorption. It has an analgesic effect on pain caused by osteolytic bone metastasis of cancer, and can also be used to treat hypercalcemia caused by cancer.
More
This product is a bisphosphonate drug. In vitro and animal tests have shown that it can strongly inhibit the dissolution of hydroxyapatite and the activity of osteoclasts, and has a very significant inhibitory effect on bone absorption. It has an analgesic effect on pain caused by osteolytic bone metastasis of cancer, and can also be used to treat hypercalcemia caused by cancer. |
109552-15-0 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Disodium pamidronate |
This product is a bisphosphonate drug. In vitro and animal tests have shown that it can strongly inhibit the dissolution of hydroxyapatite and the activity of osteoclasts, and has a very significant inhibitory effect on bone absorption. It has an analgesic effect on pain caused by osteolytic bone metastasis of cancer, and can also be used to treat hypercalcemia caused by cancer.
More
This product is a bisphosphonate drug. In vitro and animal tests have shown that it can strongly inhibit the dissolution of hydroxyapatite and the activity of osteoclasts, and has a very significant inhibitory effect on bone absorption. It has an analgesic effect on pain caused by osteolytic bone metastasis of cancer, and can also be used to treat hypercalcemia caused by cancer. |
109552-15-0 | 28 |